{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T21:04:15Z","timestamp":1768079055510,"version":"3.49.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2009,5,15]],"date-time":"2009-05-15T00:00:00Z","timestamp":1242345600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s10585-009-9264-9","type":"journal-article","created":{"date-parts":[[2009,5,14]],"date-time":"2009-05-14T09:13:06Z","timestamp":1242292386000},"page":"653-661","source":"Crossref","is-referenced-by-count":51,"title":["Activated platelets enhance ovarian cancer cell invasion in a cellular model of metastasis"],"prefix":"10.1007","volume":"26","author":[{"given":"C. E.","family":"Holmes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. E.","family":"Levis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. L.","family":"Ornstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,5,15]]},"reference":[{"issue":"5","key":"9264_CR1","first-page":"511","volume":"74","author":"MA Sarach","year":"1993","unstructured":"Sarach MA, Rovasio RA, Eynard AR (1993) Platelet factors induce chemotactic migration of murine mammary adenocarcinoma cells with different metastatic capabilities. Int J Exp Pathol 74(5):511\u2013517","journal-title":"Int J Exp Pathol"},{"issue":"1","key":"9264_CR2","first-page":"18","volume":"18","author":"A Poggi","year":"1988","unstructured":"Poggi A, Vicenzi E, Cioce V et al (1988) Platelet contribution to cancer cell growth and migration: the role of platelet growth factors. Haemostasis 18(1):18\u201328","journal-title":"Haemostasis"},{"issue":"3","key":"9264_CR3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/ijc.2910600324","volume":"60","author":"C Belloc","year":"1995","unstructured":"Belloc C, Lu H, Soria C et al (1995) The effect of platelets on invasiveness and protease production of human mammary tumor cells. Int J Cancer 60(3):413\u2013417. doi: 10.1002\/ijc.2910600324","journal-title":"Int J Cancer"},{"issue":"4","key":"9264_CR4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0049-3848(91)90149-Q","volume":"62","author":"JM Lewalle","year":"1991","unstructured":"Lewalle JM, Castronovo V, Goffinet G et al (1991) Malignant cell attachment to endothelium of ex vivo perfused human umbilical vein. Modulation by platelets, plasma and fibronectin. Thromb Res 62(4):287\u2013298. doi: 10.1016\/0049-3848(91)90149-Q","journal-title":"Thromb Res"},{"issue":"4","key":"9264_CR5","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1073\/pnas.98.4.1853","volume":"98","author":"B Felding-Habermann","year":"2001","unstructured":"Felding-Habermann B, O\u2019Toole TE, Smith JW et al (2001) Integrin activation controls metastasis in human breast cancer. Proc Natl Acad Sci USA 98(4):1853\u20131858. doi: 10.1073\/pnas.98.4.1853","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"9264_CR6","first-page":"493","volume":"46","author":"DS Jones","year":"1971","unstructured":"Jones DS, Wallace AC, Fraser EE (1971) Sequence of events in experimental metastases of Walker 256 tumor: light, immunofluorescent, and electron microscopic observations. J Natl Cancer Inst 46(3):493\u2013504","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"9264_CR7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(02)00789-1","volume":"3","author":"GF Nash","year":"2002","unstructured":"Nash GF, Turner LF, Scully MF et al (2002) Platelets and cancer. Lancet Oncol 3(7):425\u2013430. doi: 10.1016\/S1470-2045(02)00789-1","journal-title":"Lancet Oncol"},{"issue":"1","key":"9264_CR8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1124\/jpet.106.103358","volume":"318","author":"D Alonso-Escolano","year":"2006","unstructured":"Alonso-Escolano D, Medina C, Cieslik K et al (2006) Protein kinase C{delta} mediates platelet-induced breast cancer cell invasion. J Pharmacol Exp Ther 318(1):373\u2013380. doi: 10.1124\/jpet.106.103358","journal-title":"J Pharmacol Exp Ther"},{"issue":"12","key":"9264_CR9","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1172\/JCI200422123","volume":"114","author":"A Boucharaba","year":"2004","unstructured":"Boucharaba A, Serre CM, Gres S et al (2004) Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer. J Clin Invest 114(12):1714\u20131725","journal-title":"J Clin Invest"},{"issue":"4","key":"9264_CR10","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1083\/jcb.102.4.1217","volume":"102","author":"RK Assoian","year":"1986","unstructured":"Assoian RK, Sporn MB (1986) Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J Cell Biol 102(4):1217\u20131223. doi: 10.1083\/jcb.102.4.1217","journal-title":"J Cell Biol"},{"issue":"12 Pt 1","key":"9264_CR11","first-page":"2187","volume":"3","author":"HM Verheul","year":"1997","unstructured":"Verheul HM, Hoekman K, Luykx-de Bakker S et al (1997) Platelet: transporter of vascular endothelial growth factor. Clin Cancer Res 3(12 Pt 1):2187\u20132190","journal-title":"Clin Cancer Res"},{"issue":"10","key":"9264_CR12","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1161\/01.ATV.17.10.2293","volume":"17","author":"V Dubernard","year":"1997","unstructured":"Dubernard V, Arbeille BB, Lemesle MB et al (1997) Evidence for an alpha-granular pool of the cytoskeletal protein alpha-actinin in human platelets that redistributes with the adhesive glycoprotein thrombospondin-1 during the exocytotic process. Arterioscler Thromb Vasc Biol 17(10):2293\u20132305","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"9264_CR13","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1182\/blood.V53.4.604.604","volume":"53","author":"KL Kaplan","year":"1979","unstructured":"Kaplan KL, Broekman MJ, Chernoff A et al (1979) Platelet alpha-granule proteins: studies on release and subcellular localization. Blood 53(4):604\u2013618","journal-title":"Blood"},{"issue":"11","key":"9264_CR14","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1182\/blood-2006-07-038539","volume":"109","author":"JA Coppinger","year":"2007","unstructured":"Coppinger JA, O\u2019Connor R, Wynne K et al (2007) Moderation of the platelet releasate response by aspirin. Blood 109(11):4786\u20134792. doi: 10.1182\/blood-2006-07-038539","journal-title":"Blood"},{"issue":"1","key":"9264_CR15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1073\/pnas.0406682102","volume":"102","author":"L Ma","year":"2005","unstructured":"Ma L, Perini R, McKnight W et al (2005) Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets. Proc Natl Acad Sci USA 102(1):216\u2013220. doi: 10.1073\/pnas.0406682102","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"9264_CR16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00001721-199003000-00010","volume":"1","author":"LR Zacharski","year":"1990","unstructured":"Zacharski LR, Memoli VA, Costantini V et al (1990) Clotting factors in tumour tissue: implications for cancer therapy. Blood Coagul Fibrinolysis 1(1):71\u201378. doi: 10.1097\/00001721-199003000-00010","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"15","key":"9264_CR17","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/jnci\/85.15.1225","volume":"85","author":"LR Zacharski","year":"1993","unstructured":"Zacharski LR, Memoli VA, Ornstein DL et al (1993) Tumor cell procoagulant and urokinase expression in carcinoma of the ovary. J Natl Cancer Inst 85(15):1225\u20131230. doi: 10.1093\/jnci\/85.15.1225","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"9264_CR18","first-page":"4348","volume":"42","author":"E Bastida","year":"1982","unstructured":"Bastida E, Ordinas A, Giardina SL et al (1982) Differentiation of platelet-aggregating effects of human tumor cell lines based on inhibition studies with apyrase, hirudin, and phospholipase. Cancer Res 42(11):4348\u20134352","journal-title":"Cancer Res"},{"issue":"6","key":"9264_CR19","first-page":"1743","volume":"7","author":"G Konecny","year":"2001","unstructured":"Konecny G, Untch M, Pihan A et al (2001) Association of urokinase-type plasminogen activator and its inhibitor with disease progression and prognosis in ovarian cancer. Clin Cancer Res 7(6):1743\u20131749","journal-title":"Clin Cancer Res"},{"issue":"11\u201312","key":"9264_CR20","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1038\/sj.bjc.6690278","volume":"79","author":"W Kuhn","year":"1999","unstructured":"Kuhn W, Schmalfeldt B, Reuning U et al (1999) Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc. Br J Cancer 79(11\u201312):1746\u20131751. doi: 10.1038\/sj.bjc.6690278","journal-title":"Br J Cancer"},{"issue":"18","key":"9264_CR21","first-page":"3958","volume":"55","author":"B Schmalfeldt","year":"1995","unstructured":"Schmalfeldt B, Kuhn W, Reuning U et al (1995) Primary tumor and metastasis in ovarian cancer differ in their content of urokinase-type plasminogen activator, its receptor, and inhibitors types 1 and 2. Cancer Res 55(18):3958\u20133963","journal-title":"Cancer Res"},{"key":"9264_CR22","doi-asserted-by":"crossref","unstructured":"Agis H, Kandler B, Fischer MB et al. (2008) Activated platelets increase fibrinolysis of mesenchymal progenitor cells. J Orthop Res. doi: 10.1002\/jor.20819","DOI":"10.1002\/jor.20819"},{"issue":"14","key":"9264_CR23","doi-asserted-by":"crossref","first-page":"9121","DOI":"10.1016\/S0021-9258(17)47274-7","volume":"259","author":"S Hsu-Lin","year":"1984","unstructured":"Hsu-Lin S, Berman CL, Furie BC et al (1984) A platelet membrane protein expressed during platelet activation and secretion. Studies using a monoclonal antibody specific for thrombin-activated platelets. J Biol Chem 259(14):9121\u20139126","journal-title":"J Biol Chem"},{"issue":"2","key":"9264_CR24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ajh.10097","volume":"70","author":"D Gurney","year":"2002","unstructured":"Gurney D, Lip GY, Blann AD (2002) A reliable plasma marker of platelet activation: does it exist? Am J Hematol 70(2):139\u2013144. doi: 10.1002\/ajh.10097","journal-title":"Am J Hematol"},{"issue":"2","key":"9264_CR25","first-page":"69","volume":"38","author":"GH Rao","year":"1994","unstructured":"Rao GH, Rao AT (1994) Pharmacology of platelet activation-inhibitory drugs. Indian J Physiol Pharmacol 38(2):69\u201384","journal-title":"Indian J Physiol Pharmacol"},{"issue":"13","key":"9264_CR26","first-page":"3610","volume":"52","author":"H Kobayashi","year":"1992","unstructured":"Kobayashi H, Ohi H, Sugimura M et al (1992) Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B. Cancer Res 52(13):3610\u20133614","journal-title":"Cancer Res"},{"issue":"2","key":"9264_CR27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0014-5793(94)80259-9","volume":"337","author":"O Wilhelm","year":"1994","unstructured":"Wilhelm O, Weidle U, Hohl S et al (1994) Recombinant soluble urokinase receptor as a scavenger for urokinase-type plasminogen activator (uPA). Inhibition of proliferation and invasion of human ovarian cancer cells. FEBS Lett 337(2):131\u2013134. doi: 10.1016\/0014-5793(94)80259-9","journal-title":"FEBS Lett"},{"issue":"17","key":"9264_CR28","doi-asserted-by":"crossref","first-page":"9709","DOI":"10.1074\/jbc.270.17.9709","volume":"270","author":"SJ Mandriota","year":"1995","unstructured":"Mandriota SJ, Seghezzi G, Vassalli JD et al (1995) Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. J Biol Chem 270(17):9709\u20139716. doi: 10.1074\/jbc.270.17.9709","journal-title":"J Biol Chem"},{"issue":"2","key":"9264_CR29","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/0006-291X(91)91276-I","volume":"181","author":"MS Pepper","year":"1991","unstructured":"Pepper MS, Ferrara N, Orci L et al (1991) Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 181(2):902\u2013906. doi: 10.1016\/0006-291X(91)91276-I","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"9264_CR30","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1158\/1078-0432.CCR-07-4640","volume":"14","author":"CE Holmes","year":"2008","unstructured":"Holmes CE, Huang JC, Pace TR et al (2008) Tamoxifen and aromatase inhibitors differentially affect vascular endothelial growth factor and endostatin levels in women with breast cancer. Clin Cancer Res 14(10):3070\u20133076. doi: 10.1158\/1078-0432.CCR-07-4640","journal-title":"Clin Cancer Res"},{"issue":"1","key":"9264_CR31","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/01.AOG.0000102703.21556.0B","volume":"103","author":"N Bozkurt","year":"2004","unstructured":"Bozkurt N, Yuce K, Basaran M et al (2004) Correlation of platelet count with second-look laparotomy results and disease progression in patients with advanced epithelial ovarian cancer. Obstet Gynecol 103(1):82\u201385","journal-title":"Obstet Gynecol"},{"issue":"21","key":"9264_CR32","doi-asserted-by":"crossref","first-page":"9024","DOI":"10.1073\/pnas.0700625104","volume":"104","author":"S Jain","year":"2007","unstructured":"Jain S, Zuka M, Liu J et al (2007) Platelet glycoprotein Ib alpha supports experimental lung metastasis. Proc Natl Acad Sci USA 104(21):9024\u20139028. doi: 10.1073\/pnas.0700625104","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"9264_CR33","doi-asserted-by":"crossref","first-page":"C907","DOI":"10.1152\/ajpcell.00463.2007","volume":"294","author":"CS Alves","year":"2008","unstructured":"Alves CS, Burdick MM, Thomas SN et al (2008) The dual role of CD44 as a functional P-selectin ligand and fibrin receptor in colon carcinoma cell adhesion. Am J Physiol Cell Physiol 294(4):C907\u2013C916. doi: 10.1152\/ajpcell.00463.2007","journal-title":"Am J Physiol Cell Physiol"},{"issue":"10","key":"9264_CR34","first-page":"2824","volume":"62","author":"M Trikha","year":"2002","unstructured":"Trikha M, Zhou Z, Timar J et al (2002) Multiple roles for platelet GPIIb\/IIIa and alphavbeta3 integrins in tumor growth, angiogenesis, and metastasis. Cancer Res 62(10):2824\u20132833","journal-title":"Cancer Res"},{"issue":"1","key":"9264_CR35","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1182\/blood-2004-06-2272","volume":"105","author":"JS Palumbo","year":"2005","unstructured":"Palumbo JS, Talmage KE, Massari JV et al (2005) Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood 105(1):178\u2013185. doi: 10.1182\/blood-2004-06-2272","journal-title":"Blood"},{"issue":"6","key":"9264_CR36","first-page":"1295","volume":"59","author":"B Nieswandt","year":"1999","unstructured":"Nieswandt B, Hafner M, Echtenacher B et al (1999) Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res 59(6):1295\u20131300","journal-title":"Cancer Res"},{"issue":"4","key":"9264_CR37","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0002-9440(10)64398-2","volume":"161","author":"G Kristiansen","year":"2002","unstructured":"Kristiansen G, Denkert C, Schluns K et al (2002) CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival. Am J Pathol 161(4):1215\u20131221","journal-title":"Am J Pathol"},{"issue":"2","key":"9264_CR38","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00006676-200408000-00008","volume":"29","author":"K Suzuki","year":"2004","unstructured":"Suzuki K, Aiura K, Ueda M et al (2004) The influence of platelets on the promotion of invasion by tumor cells and inhibition by antiplatelet agents. Pancreas 29(2):132\u2013140. doi: 10.1097\/00006676-200408000-00008","journal-title":"Pancreas"},{"issue":"3","key":"9264_CR39","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1042\/bj2710815","volume":"271","author":"W Siess","year":"1990","unstructured":"Siess W, Lapetina EG (1990) Functional relationship between cyclic AMP-dependent protein phosphorylation and platelet inhibition. Biochem J 271(3):815\u2013819","journal-title":"Biochem J"},{"issue":"5","key":"9264_CR40","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.bjp.0704559","volume":"135","author":"AW Chung","year":"2002","unstructured":"Chung AW, Jurasz P, Hollenberg MD et al (2002) Mechanisms of action of proteinase-activated receptor agonists on human platelets. Br J Pharmacol 135(5):1123\u20131132. doi: 10.1038\/sj.bjp.0704559","journal-title":"Br J Pharmacol"},{"issue":"6","key":"9264_CR41","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1172\/JCI6042","volume":"103","author":"ML Kahn","year":"1999","unstructured":"Kahn ML, Nakanishi-Matsui M, Shapiro MJ et al (1999) Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest 103(6):879\u2013887. doi: 10.1172\/JCI6042","journal-title":"J Clin Invest"},{"issue":"6","key":"9264_CR42","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/0092-8674(91)90261-V","volume":"64","author":"TK Vu","year":"1991","unstructured":"Vu TK, Hung DT, Wheaton VI et al (1991) Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64(6):1057\u20131068. doi: 10.1016\/0092-8674(91)90261-V","journal-title":"Cell"},{"issue":"5","key":"9264_CR43","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ccr.2006.10.002","volume":"10","author":"ML Nierodzik","year":"2006","unstructured":"Nierodzik ML, Karpatkin S (2006) Thrombin induces tumor growth, metastasis, and angiogenesis: evidence for a thrombin-regulated dormant tumor phenotype. Cancer Cell 10(5):355\u2013362. doi: 10.1016\/j.ccr.2006.10.002","journal-title":"Cancer Cell"},{"issue":"12","key":"9264_CR44","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1038\/bjc.1998.349","volume":"77","author":"R Dardik","year":"1998","unstructured":"Dardik R, Savion N, Kaufmann Y et al (1998) Thrombin promotes platelet-mediated melanoma cell adhesion to endothelial cells under flow conditions: role of platelet glycoproteins P-selectin and GPIIb-IIIA. Br J Cancer 77(12):2069\u20132075","journal-title":"Br J Cancer"},{"issue":"5","key":"9264_CR45","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/ijc.20657","volume":"113","author":"A Janowska-Wieczorek","year":"2005","unstructured":"Janowska-Wieczorek A, Wysoczynski M, Kijowski J et al (2005) Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer 113(5):752\u2013760. doi: 10.1002\/ijc.20657","journal-title":"Int J Cancer"},{"issue":"7","key":"9264_CR46","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1537-2995.2006.00871.x","volume":"46","author":"A Janowska-Wieczorek","year":"2006","unstructured":"Janowska-Wieczorek A, Marquez-Curtis LA, Wysoczynski M et al (2006) Enhancing effect of platelet-derived microvesicles on the invasive potential of breast cancer cells. Transfusion 46(7):1199\u20131209. doi: 10.1111\/j.1537-2995.2006.00871.x","journal-title":"Transfusion"},{"issue":"1","key":"9264_CR47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1023\/A:1006190729866","volume":"55","author":"AM Sieuwerts","year":"1999","unstructured":"Sieuwerts AM, Klijn JG, Henzen-Logmans SC et al (1999) Cytokine-regulated urokinase-type-plasminogen-activator (uPA) production by human breast fibroblasts in vitro. Breast Cancer Res Treat 55(1):9\u201320. doi: 10.1023\/A:1006190729866","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"9264_CR48","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1006\/gyno.2000.6042","volume":"80","author":"GC Rodriguez","year":"2001","unstructured":"Rodriguez GC, Haisley C, Hurteau J et al (2001) Regulation of invasion of epithelial ovarian cancer by transforming growth factor-beta. Gynecol Oncol 80(2):245\u2013253. doi: 10.1006\/gyno.2000.6042","journal-title":"Gynecol Oncol"},{"issue":"45","key":"9264_CR49","doi-asserted-by":"crossref","first-page":"33971","DOI":"10.1074\/jbc.M607010200","volume":"281","author":"SR Shiou","year":"2006","unstructured":"Shiou SR, Datta PK, Dhawan P et al (2006) Smad4-dependent regulation of urokinase plasminogen activator secretion and RNA stability associated with invasiveness by autocrine and paracrine transforming growth factor-beta. J Biol Chem 281(45):33971\u201333981. doi: 10.1074\/jbc.M607010200","journal-title":"J Biol Chem"},{"issue":"1","key":"9264_CR50","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1182\/blood.V63.1.55.55","volume":"63","author":"P Mehta","year":"1984","unstructured":"Mehta P (1984) Potential role of platelets in the pathogenesis of tumor metastasis. Blood 63(1):55\u201363","journal-title":"Blood"},{"issue":"11","key":"9264_CR51","first-page":"3704","volume":"5","author":"TB Pustilnik","year":"1999","unstructured":"Pustilnik TB, Estrella V, Wiener JR et al (1999) Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells. Clin Cancer Res 5(11):3704\u20133710","journal-title":"Clin Cancer Res"},{"issue":"2","key":"9264_CR52","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ygyno.2007.10.027","volume":"108","author":"OD Gil","year":"2008","unstructured":"Gil OD, Lee C, Ariztia EV et al (2008) Lysophosphatidic acid (LPA) promotes E-cadherin ectodomain shedding and OVCA429 cell invasion in an uPA-dependent manner. Gynecol Oncol 108(2):361\u2013369. doi: 10.1016\/j.ygyno.2007.10.027","journal-title":"Gynecol Oncol"},{"issue":"3","key":"9264_CR53","first-page":"549","volume":"90","author":"A Amirkhosravi","year":"2003","unstructured":"Amirkhosravi A, Mousa SA, Amaya M et al (2003) Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb\/IIIa antagonist XV454. Thromb Haemost 90(3):549\u2013554","journal-title":"Thromb Haemost"},{"issue":"1","key":"9264_CR54","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1055\/s-0038-1642691","volume":"74","author":"ML Nierodzik","year":"1995","unstructured":"Nierodzik ML, Klepfish A, Karpatkin S (1995) Role of platelets, thrombin, integrin IIb-IIIa, fibronectin and von Willebrand factor on tumor adhesion in vitro and metastasis in vivo. Thromb Haemost 74(1):282\u2013290","journal-title":"Thromb Haemost"},{"issue":"2","key":"9264_CR55","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1172\/JCI116654","volume":"92","author":"JP Stone","year":"1993","unstructured":"Stone JP, Wagner DD (1993) P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer. J Clin Invest 92(2):804\u2013813. doi: 10.1172\/JCI116654","journal-title":"J Clin Invest"},{"issue":"3","key":"9264_CR56","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1182\/blood-2007-09-113837","volume":"111","author":"JE Italiano Jr","year":"2008","unstructured":"Italiano JE Jr, Richardson JL, Patel-Hett S et al (2008) Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood 111(3):1227\u20131233. doi: 10.1182\/blood-2007-09-113837","journal-title":"Blood"},{"issue":"2","key":"9264_CR57","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.bjp.0705606","volume":"141","author":"D Alonso-Escolano","year":"2004","unstructured":"Alonso-Escolano D, Strongin AY, Chung AW et al (2004) Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteins. Br J Pharmacol 141(2):241\u2013252. doi: 10.1038\/sj.bjp.0705606","journal-title":"Br J Pharmacol"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-009-9264-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-009-9264-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-009-9264-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T11:41:24Z","timestamp":1633434084000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-009-9264-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,15]]},"references-count":57,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["9264"],"URL":"https:\/\/doi.org\/10.1007\/s10585-009-9264-9","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,15]]}}}